| Related Articles |
Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity.
Angiogenesis. 2017 Apr 18;:
Authors: Rovithi M, Verheul HMW
PMID: 28421290 [PubMed - as supplied by publisher]
http://ift.tt/2o6XLzZ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου